#TRSS2606366AFrance updates indicative permanent incapacity scales for workplace accidents and occupational diseases
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This order sets indicative scales for assessing permanent incapacity linked to workplace accidents and occupational diseases under the French social security system. The annexes list percentage ranges for many medical conditions, including cardiovascular, skin, digestive, neurological, kidney, respiratory, blood, rheumatic, radiation-related and cancer conditions. The main practical effect is on compensation assessments. Medical evaluators, social security bodies, employers, insurers and affected workers will use these benchmarks to estimate permanent impairment rates, while still considering each person’s actual health impact and ability to work.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Establishes indicative permanent incapacity scales for workplace accidents and occupational diseases
- Defines percentage ranges for a wide set of occupational disease sequelae across major medical categories
- Provides assessment benchmarks for compensation decisions under the French social security system
Obligations
What this law requires
Use the indicative permanent professional incapacity scales in Annex I for workplace accidents and Annex II for occupational diseases when assessing permanent incapacity under Article L. 434-1 A of the French Social Security Code.
When assessing occupational disease-related cardiovascular sequelae, classify the condition by severity category and apply the corresponding indicative incapacity percentage range stated in the Annex II scale, while separately evaluating sequelae such as embolic migration or amputation where the scale directs separate assessment.
Do not award permanent incapacity compensation for labile borderline hypertension that does not require treatment; for permanent hypertension requiring treatment, assess both the hypertensive condition and any visceral effects, compensating visceral effects under their separate applicable scale chapters.
For occupational dermatological conditions, assess incapacity globally by considering the base clinical sequelae rate, any topography or surface-area multiplier, any complementary rate for sensory or motor sequelae, and the impact on the worker’s professional aptitude and qualification.
For allergic occupational dermatoses, account for the risk of recurrence upon renewed contact with the etiological factor and consider whether a workplace reassignment is necessary even where clinical sequelae are minimal, especially for chemical risks involving carcinogenic substances.